DRviaSPCN (Q113676): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Removed claim: imports (P585): xml2 (Q34529)
Importer (talk | contribs)
Changed an Item
Property / last update
3 March 2022
Timestamp+2022-03-03T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / last update: 3 March 2022 / rank
Normal rank
 
Property / software version identifier
 
0.1.0
Property / software version identifier: 0.1.0 / rank
 
Normal rank
Property / software version identifier: 0.1.0 / qualifier
 
publication date: 9 December 2021
Timestamp+2021-12-09T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.1.1
Property / software version identifier: 0.1.1 / rank
 
Normal rank
Property / software version identifier: 0.1.1 / qualifier
 
publication date: 28 February 2022
Timestamp+2022-02-28T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.1.3
Property / software version identifier: 0.1.3 / rank
 
Normal rank
Property / software version identifier: 0.1.3 / qualifier
 
publication date: 25 September 2023
Timestamp+2023-09-25T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / software version identifier
 
0.1.4
Property / software version identifier: 0.1.4 / rank
 
Normal rank
Property / software version identifier: 0.1.4 / qualifier
 
publication date: 13 January 2024
Timestamp+2024-01-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / last update
 
13 January 2024
Timestamp+2024-01-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / last update: 13 January 2024 / rank
 
Normal rank
Property / description
 
A systematic biology tool was developed to repurpose drugs via a subpathway crosstalk network. The operation modes include 1) calculating centrality scores of SPs in the context of gene expression data to reflect the influence of SP crosstalk, 2) evaluating drug-disease reverse association based on disease- and drug-induced SPs weighted by the SP crosstalk, 3) identifying cancer candidate drugs through perturbation analysis. There are also several functions used to visualize the results.
Property / description: A systematic biology tool was developed to repurpose drugs via a subpathway crosstalk network. The operation modes include 1) calculating centrality scores of SPs in the context of gene expression data to reflect the influence of SP crosstalk, 2) evaluating drug-disease reverse association based on disease- and drug-induced SPs weighted by the SP crosstalk, 3) identifying cancer candidate drugs through perturbation analysis. There are also several functions used to visualize the results. / rank
 
Normal rank
Property / author
 
Property / author: Junwei Han / rank
 
Normal rank
Property / author
 
Property / author: Jiashuo Wu / rank
 
Normal rank
Property / copyright license
 
Property / copyright license: GNU General Public License, version 2.0 / rank
 
Normal rank
Property / copyright license
 
Property / copyright license: GNU General Public License, version 3.0 / rank
 
Normal rank
Property / copyright license: GNU General Public License, version 3.0 / qualifier
 
edition/version: expanded from: GPL (≥ 2) (English)
Property / depends on software
 
Property / depends on software: R / rank
 
Normal rank
Property / depends on software: R / qualifier
 
Property / imports
 
Property / imports: GSVA / rank
 
Normal rank
Property / imports
 
Property / imports: clusterProfiler / rank
 
Normal rank
Property / imports
 
Property / imports: graphics / rank
 
Normal rank
Property / imports
 
Property / imports: igraph / rank
 
Normal rank
Property / imports
 
Property / imports: pheatmap / rank
 
Normal rank
Property / imports
 
Property / imports: stats / rank
 
Normal rank
Property / imports
 
Property / imports: sp / rank
 
Normal rank
Property / imports
 
Property / imports: ChemmineR / rank
 
Normal rank

Revision as of 15:56, 27 February 2024

Drug Repurposing in Cancer via a Subpathway Crosstalk Network
Language Label Description Also known as
English
DRviaSPCN
Drug Repurposing in Cancer via a Subpathway Crosstalk Network

    Statements

    0 references
    0.1.2
    3 March 2022
    0 references
    0.1.0
    9 December 2021
    0 references
    0.1.1
    28 February 2022
    0 references
    0.1.3
    25 September 2023
    0 references
    0.1.4
    13 January 2024
    0 references
    0 references
    0 references
    0 references
    13 January 2024
    0 references
    A systematic biology tool was developed to repurpose drugs via a subpathway crosstalk network. The operation modes include 1) calculating centrality scores of SPs in the context of gene expression data to reflect the influence of SP crosstalk, 2) evaluating drug-disease reverse association based on disease- and drug-induced SPs weighted by the SP crosstalk, 3) identifying cancer candidate drugs through perturbation analysis. There are also several functions used to visualize the results.
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references